A Moderna vaccine for children aged 12-17 has been approved by the European Medicines Agency today. The EMA said it is approving Spikevax -previously Covid-19 Moderna to include use in children aged 12 to 17 years. The use of the Spikevax vaccine in children for this age group will be the same as in people aged 18 and above. “The effects of Spikevax have been investigated in a study involving 3,732 children aged 12 to 17 years. The most common side effects in children aged 12 to 17 are similar to those in people aged 18 and above.

Source: Irish Independent July 23, 2021 13:52 UTC